Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations. (Q43597758)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337216%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337216%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

main subject

prostatic hypertrophy

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337216%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

R M Herings

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337216%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J J De la Rosette

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337216%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A J Man in 't Veld

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337216%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

R D Farmer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337216%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

H G Leufkens

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337216%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 May 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337216%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Epidemiology

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337216%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337216%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337216%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

518-524

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337216%20AND%20SRC:MED&resulttype=core&format=json

A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Calcium Channel Blockers and the Risk of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Confounding and indication for treatment in evaluation of drug treatment for hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Channeling bias in the interpretation of drug effects

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Oral contraceptive switching patterns in the United Kingdom: an important potential confounding variable in studies of venous thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Selection of controls in database case-control studies: glucocorticoids and the risk of glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

The development of human benign prostatic hyperplasia with age

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Current trends in management of men with lower urinary tract symptoms and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Pharmacotherapy for benign prostatic hyperplasia--the potential for alpha 1-adrenoceptor subtype-specific blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Overview of alpha-blocker therapy for benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Meta-analysis of randomized clinical trials of finasteride

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Drug-induced chest pain and myocardial infarction. Reports to a national centre and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

A chronic disease score from automated pharmacy data

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs: population based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Treatment choice for benign prostatic hyperplasia: a matter of urologist preference?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Prevalence and detection of micturition problems among 2,734 elderly men

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Prostate symptoms in general practice: seriousness and inconvenience

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Natural history of benign prostatic hyperplasia: appropriate case definition and estimation of its prevalence in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900327-9

7 January 2021

10.1016/S0895-4356(00)00327-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11337216%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference